179 related articles for article (PubMed ID: 34982371)
1. The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis.
Chen JS; Clarke R; Haddad AF; Wang EJ; Lacroix M; Sarkar IN; Zand R; Chen ES; Toms SA
J Neurooncol; 2022 Jan; 156(2):257-267. PubMed ID: 34982371
[TBL] [Abstract][Full Text] [Related]
2. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
Ryu JY; Min KL; Chang MJ
PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
5. Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy.
Roh TH; Moon JH; Park HH; Kim EH; Hong CK; Kim SH; Kang SG; Chang JH
Sci Rep; 2020 Jul; 10(1):10783. PubMed ID: 32612203
[TBL] [Abstract][Full Text] [Related]
6. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis.
Scicchitano BM; Sorrentino S; Proietti G; Lama G; Dobrowolny G; Catizone A; Binda E; Larocca LM; Sica G
Cancer Cell Int; 2018; 18():136. PubMed ID: 30214378
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
Cardona AF; Rojas L; Wills B; Bernal L; Ruiz-Patiño A; Arrieta O; Hakim EJ; Hakim F; Mejía JA; Useche N; Bermúdez S; Carranza H; Vargas C; Otero J; Mayor LC; Ortíz LD; Franco S; Ortíz C; Gil-Gil M; Balaña C; Zatarain-Barrón ZL
J Neurooncol; 2018 Jan; 136(2):363-371. PubMed ID: 29177594
[TBL] [Abstract][Full Text] [Related]
9. How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis.
Jabbarli R; Ahmadipour Y; Rauschenbach L; Santos AN; Darkwah Oppong M; Pierscianek D; Quesada CM; Kebir S; Dammann P; Guberina N; Scheffler B; Kaier K; Stuschke M; Sure U; Wrede KH
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359673
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
Carlson BL; Grogan PT; Mladek AC; Schroeder MA; Kitange GJ; Decker PA; Giannini C; Wu W; Ballman KA; James CD; Sarkaria JN
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):212-9. PubMed ID: 19695438
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.
Bobustuc GC; Baker CH; Limaye A; Jenkins WD; Pearl G; Avgeropoulos NG; Konduri SD
Neuro Oncol; 2010 Sep; 12(9):917-27. PubMed ID: 20525765
[TBL] [Abstract][Full Text] [Related]
12. The strategy for enhancing temozolomide against malignant glioma.
Nakada M; Furuta T; Hayashi Y; Minamoto T; Hamada J
Front Oncol; 2012; 2():98. PubMed ID: 22912934
[TBL] [Abstract][Full Text] [Related]
13. O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.
Spiegl-Kreinecker S; Pirker C; Filipits M; Lötsch D; Buchroithner J; Pichler J; Silye R; Weis S; Micksche M; Fischer J; Berger W
Neuro Oncol; 2010 Jan; 12(1):28-36. PubMed ID: 20150365
[TBL] [Abstract][Full Text] [Related]
14. Antiseizure medication in patients with Glioblastoma- a collaborative cohort study.
Knudsen-Baas KM; Storstein AM; Zarabla A; Maialetti A; Giannarelli D; Beghi E; Maschio M
Seizure; 2021 Apr; 87():107-113. PubMed ID: 33761391
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Significance of O
Zhao YH; Wang ZF; Cao CJ; Weng H; Xu CS; Li K; Li JL; Lan J; Zeng XT; Li ZQ
Front Neurol; 2018; 9():127. PubMed ID: 29619003
[TBL] [Abstract][Full Text] [Related]
16. Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells.
Taspinar M; Ilgaz S; Ozdemir M; Ozkan T; Oztuna D; Canpinar H; Rey JA; Sunguroğlu A; Castresana JS; Ugur HC
Tumour Biol; 2013 Jun; 34(3):1935-47. PubMed ID: 23519841
[TBL] [Abstract][Full Text] [Related]
17. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
18. Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
Yamada T; Tsuji S; Nakamura S; Egashira Y; Shimazawa M; Nakayama N; Yano H; Iwama T; Hara H
J Neurosurg; 2020 Mar; 134(3):701-710. PubMed ID: 32168477
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial.
Sun M; Huang N; Tao Y; Wen R; Zhao G; Zhang X; Xie Z; Cheng Y; Mao J; Liu G
Trials; 2022 Mar; 23(1):234. PubMed ID: 35346332
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.
Binabaj MM; Bahrami A; ShahidSales S; Joodi M; Joudi Mashhad M; Hassanian SM; Anvari K; Avan A
J Cell Physiol; 2018 Jan; 233(1):378-386. PubMed ID: 28266716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
